MPM Asset Management Investors BV2014 LLC Plans to Sell Common Shares of Werewolf Therapeutics, Inc.

MPM Asset Management Investors BV2014 LLC has filed a Form 144 with the SEC, indicating its intention to sell 4,479 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The notice was signed by Kristen Laguerre on October 27, 2025, and the plan was adopted on September 24, 2025. The aggregate market value of the shares to be sold is approximately $7,927.83. The sale is expected to occur on or around October 27, 2025, through Merrill Lynch. There are no recent transactions to report in the past three months.